Industry Research Reports

Home > Reports > Service & Software > Blood Plasma Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Blood Plasma Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published: 2024-01-24

Pages: 106 Pages

Report ld: 2343106

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Plasma, the major component of blood, is vital to the regulation of body functions. Blood plasma consists of several useful components such as albumin, coagulation factors, protease inhibitors and immunoglobulins. Since deficiencies in a component can result in the onset of a disease, both basic and targeted R&D has accelerated in this area. Blood plasma is part of an effective therapeutic treatment plan in various therapies due to its potential in battling several chronic and life-threatening diseases
The global market for Blood Plasma Products was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Products, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blood Plasma Products by region & country, by Type, and by Application.

The Blood Plasma Products market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Products.

Market Segmentation

Report Metric
Details
Report Title
Blood Plasma Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Blood Plasma Products Companies Covered
CSL Ltd., Creat Group Corporation, Grifols SA, Takeda, Octapharma AG, Kedrion SpA, Biotest AG, China Biologic Products, Sanquin, LFB S.A.
Global Blood Plasma Products Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Plasma Products Market, Segment by Type
Immunoglobulins

Coagulation Factor Concentrates

Other
Global Blood Plasma Products Market, Segment by Application
Hospitals And Clinics

Research Laboratories

Academic Institutions
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blood Plasma Products manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Blood Plasma Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Blood Plasma Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Blood Plasma Products Product Introduction
    1.2 Global Blood Plasma Products Market Size Forecast
    1.3 Blood Plasma Products Market Trends & Drivers
        1.3.1 Blood Plasma Products Industry Trends
        1.3.2 Blood Plasma Products Market Drivers & Opportunity
        1.3.3 Blood Plasma Products Market Challenges
        1.3.4 Blood Plasma Products Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Blood Plasma Products Players Revenue Ranking (2023)
    2.2 Global Blood Plasma Products Revenue by Company (2019-2024)
    2.3 Key Companies Blood Plasma Products Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Blood Plasma Products Product Offered
    2.5 Key Companies Time to Begin Mass Production of Blood Plasma Products
    2.6 Blood Plasma Products Market Competitive Analysis
        2.6.1 Blood Plasma Products Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Blood Plasma Products Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Products as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Immunoglobulins
        3.1.2 Coagulation Factor Concentrates
        3.1.3 Other
    3.2 Global Blood Plasma Products Sales Value by Type
        3.2.1 Global Blood Plasma Products Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Blood Plasma Products Sales Value, by Type (2019-2030)
        3.2.3 Global Blood Plasma Products Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals And Clinics
        4.1.2 Research Laboratories
        4.1.3 Academic Institutions
    4.2 Global Blood Plasma Products Sales Value by Application
        4.2.1 Global Blood Plasma Products Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Blood Plasma Products Sales Value, by Application (2019-2030)
        4.2.3 Global Blood Plasma Products Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Blood Plasma Products Sales Value by Region
        5.1.1 Global Blood Plasma Products Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Blood Plasma Products Sales Value by Region (2019-2024)
        5.1.3 Global Blood Plasma Products Sales Value by Region (2025-2030)
        5.1.4 Global Blood Plasma Products Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Blood Plasma Products Sales Value, 2019-2030
        5.2.2 North America Blood Plasma Products Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Blood Plasma Products Sales Value, 2019-2030
        5.3.2 Europe Blood Plasma Products Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Blood Plasma Products Sales Value, 2019-2030
        5.4.2 Asia Pacific Blood Plasma Products Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Blood Plasma Products Sales Value, 2019-2030
        5.5.2 South America Blood Plasma Products Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Blood Plasma Products Sales Value, 2019-2030
        5.6.2 Middle East & Africa Blood Plasma Products Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Blood Plasma Products Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Blood Plasma Products Sales Value
    6.3 United States
        6.3.1 United States Blood Plasma Products Sales Value, 2019-2030
        6.3.2 United States Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Blood Plasma Products Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Blood Plasma Products Sales Value, 2019-2030
        6.4.2 Europe Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Blood Plasma Products Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Blood Plasma Products Sales Value, 2019-2030
        6.5.2 China Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Blood Plasma Products Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Blood Plasma Products Sales Value, 2019-2030
        6.6.2 Japan Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Blood Plasma Products Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Blood Plasma Products Sales Value, 2019-2030
        6.7.2 South Korea Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Blood Plasma Products Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Blood Plasma Products Sales Value, 2019-2030
        6.8.2 Southeast Asia Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Blood Plasma Products Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Blood Plasma Products Sales Value, 2019-2030
        6.9.2 India Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Blood Plasma Products Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 CSL Ltd.
        7.1.1 CSL Ltd. Profile
        7.1.2 CSL Ltd. Main Business
        7.1.3 CSL Ltd. Blood Plasma Products Products, Services and Solutions
        7.1.4 CSL Ltd. Blood Plasma Products Revenue (US$ Million) & (2019-2024)
        7.1.5 CSL Ltd. Recent Developments
    7.2 Creat Group Corporation
        7.2.1 Creat Group Corporation Profile
        7.2.2 Creat Group Corporation Main Business
        7.2.3 Creat Group Corporation Blood Plasma Products Products, Services and Solutions
        7.2.4 Creat Group Corporation Blood Plasma Products Revenue (US$ Million) & (2019-2024)
        7.2.5 Creat Group Corporation Recent Developments
    7.3 Grifols SA
        7.3.1 Grifols SA Profile
        7.3.2 Grifols SA Main Business
        7.3.3 Grifols SA Blood Plasma Products Products, Services and Solutions
        7.3.4 Grifols SA Blood Plasma Products Revenue (US$ Million) & (2019-2024)
        7.3.5 Takeda Recent Developments
    7.4 Takeda
        7.4.1 Takeda Profile
        7.4.2 Takeda Main Business
        7.4.3 Takeda Blood Plasma Products Products, Services and Solutions
        7.4.4 Takeda Blood Plasma Products Revenue (US$ Million) & (2019-2024)
        7.4.5 Takeda Recent Developments
    7.5 Octapharma AG
        7.5.1 Octapharma AG Profile
        7.5.2 Octapharma AG Main Business
        7.5.3 Octapharma AG Blood Plasma Products Products, Services and Solutions
        7.5.4 Octapharma AG Blood Plasma Products Revenue (US$ Million) & (2019-2024)
        7.5.5 Octapharma AG Recent Developments
    7.6 Kedrion SpA
        7.6.1 Kedrion SpA Profile
        7.6.2 Kedrion SpA Main Business
        7.6.3 Kedrion SpA Blood Plasma Products Products, Services and Solutions
        7.6.4 Kedrion SpA Blood Plasma Products Revenue (US$ Million) & (2019-2024)
        7.6.5 Kedrion SpA Recent Developments
    7.7 Biotest AG
        7.7.1 Biotest AG Profile
        7.7.2 Biotest AG Main Business
        7.7.3 Biotest AG Blood Plasma Products Products, Services and Solutions
        7.7.4 Biotest AG Blood Plasma Products Revenue (US$ Million) & (2019-2024)
        7.7.5 Biotest AG Recent Developments
    7.8 China Biologic Products
        7.8.1 China Biologic Products Profile
        7.8.2 China Biologic Products Main Business
        7.8.3 China Biologic Products Blood Plasma Products Products, Services and Solutions
        7.8.4 China Biologic Products Blood Plasma Products Revenue (US$ Million) & (2019-2024)
        7.8.5 China Biologic Products Recent Developments
    7.9 Sanquin
        7.9.1 Sanquin Profile
        7.9.2 Sanquin Main Business
        7.9.3 Sanquin Blood Plasma Products Products, Services and Solutions
        7.9.4 Sanquin Blood Plasma Products Revenue (US$ Million) & (2019-2024)
        7.9.5 Sanquin Recent Developments
    7.10 LFB S.A.
        7.10.1 LFB S.A. Profile
        7.10.2 LFB S.A. Main Business
        7.10.3 LFB S.A. Blood Plasma Products Products, Services and Solutions
        7.10.4 LFB S.A. Blood Plasma Products Revenue (US$ Million) & (2019-2024)
        7.10.5 LFB S.A. Recent Developments

 8 Industry Chain Analysis
    8.1 Blood Plasma Products Industrial Chain
    8.2 Blood Plasma Products Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Blood Plasma Products Sales Model
        8.5.2 Sales Channel
        8.5.3 Blood Plasma Products Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Blood Plasma Products Market Trends
    Table 2. Blood Plasma Products Market Drivers & Opportunity
    Table 3. Blood Plasma Products Market Challenges
    Table 4. Blood Plasma Products Market Restraints
    Table 5. Global Blood Plasma Products Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Blood Plasma Products Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Blood Plasma Products Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Blood Plasma Products Product Type
    Table 9. Key Companies Time to Begin Mass Production of Blood Plasma Products
    Table 10. Global Blood Plasma Products Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Products as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Blood Plasma Products Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Blood Plasma Products Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Blood Plasma Products Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Blood Plasma Products Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Blood Plasma Products Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Blood Plasma Products Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Blood Plasma Products Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Blood Plasma Products Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Blood Plasma Products Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Blood Plasma Products Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Blood Plasma Products Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Blood Plasma Products Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Blood Plasma Products Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Blood Plasma Products Sales Value by Region (2019-2024) & (%)
    Table 27. Global Blood Plasma Products Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Blood Plasma Products Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Blood Plasma Products Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Blood Plasma Products Sales Value, (2025-2030) & (US$ Million)
    Table 31. CSL Ltd. Basic Information List
    Table 32. CSL Ltd. Description and Business Overview
    Table 33. CSL Ltd. Blood Plasma Products Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Blood Plasma Products Business of CSL Ltd. (2019-2024)
    Table 35. CSL Ltd. Recent Developments
    Table 36. Creat Group Corporation Basic Information List
    Table 37. Creat Group Corporation Description and Business Overview
    Table 38. Creat Group Corporation Blood Plasma Products Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Blood Plasma Products Business of Creat Group Corporation (2019-2024)
    Table 40. Creat Group Corporation Recent Developments
    Table 41. Grifols SA Basic Information List
    Table 42. Grifols SA Description and Business Overview
    Table 43. Grifols SA Blood Plasma Products Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Blood Plasma Products Business of Grifols SA (2019-2024)
    Table 45. Grifols SA Recent Developments
    Table 46. Takeda Basic Information List
    Table 47. Takeda Description and Business Overview
    Table 48. Takeda Blood Plasma Products Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Blood Plasma Products Business of Takeda (2019-2024)
    Table 50. Takeda Recent Developments
    Table 51. Octapharma AG Basic Information List
    Table 52. Octapharma AG Description and Business Overview
    Table 53. Octapharma AG Blood Plasma Products Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Blood Plasma Products Business of Octapharma AG (2019-2024)
    Table 55. Octapharma AG Recent Developments
    Table 56. Kedrion SpA Basic Information List
    Table 57. Kedrion SpA Description and Business Overview
    Table 58. Kedrion SpA Blood Plasma Products Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Blood Plasma Products Business of Kedrion SpA (2019-2024)
    Table 60. Kedrion SpA Recent Developments
    Table 61. Biotest AG Basic Information List
    Table 62. Biotest AG Description and Business Overview
    Table 63. Biotest AG Blood Plasma Products Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Blood Plasma Products Business of Biotest AG (2019-2024)
    Table 65. Biotest AG Recent Developments
    Table 66. China Biologic Products Basic Information List
    Table 67. China Biologic Products Description and Business Overview
    Table 68. China Biologic Products Blood Plasma Products Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Blood Plasma Products Business of China Biologic Products (2019-2024)
    Table 70. China Biologic Products Recent Developments
    Table 71. Sanquin Basic Information List
    Table 72. Sanquin Description and Business Overview
    Table 73. Sanquin Blood Plasma Products Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Blood Plasma Products Business of Sanquin (2019-2024)
    Table 75. Sanquin Recent Developments
    Table 76. LFB S.A. Basic Information List
    Table 77. LFB S.A. Description and Business Overview
    Table 78. LFB S.A. Blood Plasma Products Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Blood Plasma Products Business of LFB S.A. (2019-2024)
    Table 80. LFB S.A. Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Blood Plasma Products Downstream Customers
    Table 84. Blood Plasma Products Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Blood Plasma Products Product Picture
    Figure 2. Global Blood Plasma Products Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Blood Plasma Products Sales Value (2019-2030) & (US$ Million)
    Figure 4. Blood Plasma Products Report Years Considered
    Figure 5. Global Blood Plasma Products Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Blood Plasma Products Revenue in 2023
    Figure 7. Blood Plasma Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Immunoglobulins Picture
    Figure 9. Coagulation Factor Concentrates Picture
    Figure 10. Other Picture
    Figure 11. Global Blood Plasma Products Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Blood Plasma Products Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospitals And Clinics
    Figure 14. Product Picture of Research Laboratories
    Figure 15. Product Picture of Academic Institutions
    Figure 16. Global Blood Plasma Products Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Blood Plasma Products Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Blood Plasma Products Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Blood Plasma Products Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Blood Plasma Products Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Blood Plasma Products Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Blood Plasma Products Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Blood Plasma Products Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Blood Plasma Products Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Blood Plasma Products Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Blood Plasma Products Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Blood Plasma Products Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Blood Plasma Products Sales Value (%), (2019-2030)
    Figure 29. United States Blood Plasma Products Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Blood Plasma Products Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Blood Plasma Products Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Blood Plasma Products Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Blood Plasma Products Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Blood Plasma Products Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Blood Plasma Products Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Blood Plasma Products Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Blood Plasma Products Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Blood Plasma Products Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Blood Plasma Products Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Blood Plasma Products Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Blood Plasma Products Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Blood Plasma Products Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Blood Plasma Products Sales Value by Application (%), 2023 VS 2030
    Figure 50. Blood Plasma Products Industrial Chain
    Figure 51. Blood Plasma Products Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

Plasma, the major component of blood, is vital to the regulation of body functions. Blood plasma consists of several useful components such as albumin, coagulation factors, protease inhibitors and immunoglobulins. Since deficiencies in a component can result in the onset of a disease, both basic and targeted R&D has accelerated in this area. Blood plasma is part of an effective therapeutic treatment plan in various therapies due to its potential in battling several chronic and life-threatening diseases
The global market for Blood Plasma Products was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Products, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blood Plasma Products by region & country, by Type, and by Application.

The Blood Plasma Products market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Products.

Market Segmentation